TY - JOUR AU - Zarogoulidis, K. AU - Zarogoulidis, P. AU - Darwiche, K. AU - Boutsikou, E. AU - Machairiotis, N. AU - Tsakiridis, K. PY - 2013 DA - 2013// TI - Treatment of non-small cell lung cancer (NSCLC) JO - J Thor Dis VL - 5 ID - Zarogoulidis2013 ER - TY - JOUR AU - Scagliotti, G. AU - Hanna, N. AU - Fossella, F. AU - Sugarman, K. AU - Blatter, J. AU - Peterson, P. PY - 2009 DA - 2009// TI - The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0232 DO - 10.1634/theoncologist.2008-0232 ID - Scagliotti2009 ER - TY - JOUR AU - Chang, A. PY - 2011 DA - 2011// TI - Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC JO - Lung Cancer VL - 71 UR - https://doi.org/10.1016/j.lungcan.2010.08.022 DO - 10.1016/j.lungcan.2010.08.022 ID - Chang2011 ER - TY - JOUR AU - Cappuzzo, F. AU - Gregorc, V. AU - Rossi, E. AU - Cancellieri, A. AU - Magrini, E. AU - Paties, C. T. PY - 2003 DA - 2003// TI - Gefitinib in pretreated non–small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.01.039 DO - 10.1200/JCO.2003.01.039 ID - Cappuzzo2003 ER - TY - JOUR AU - Hof, H. AU - Herfarth, K. K. AU - Münter, M. AU - Hoess, A. AU - Motsch, J. AU - Wannenmacher, M. PY - 2003 DA - 2003// TI - Stereotactic single-dose radiotherapy of stage I non–small-cell lung cancer (NSCLC) JO - Int J Rad Oncol Biol Phys VL - 56 UR - https://doi.org/10.1016/S0360-3016(02)04504-2 DO - 10.1016/S0360-3016(02)04504-2 ID - Hof2003 ER - TY - JOUR AU - Zhang, C. AU - Yin, D. AU - Sun, S. AU - Han, L. PY - 2017 DA - 2017// TI - The use of lncRNA analysis for stratification management of prognostic risk in patients with NSCLC JO - Eur Rev Med Pharmacol Sci VL - 21 ID - Zhang2017 ER - TY - JOUR AU - He, R. PY - 2017 DA - 2017// TI - Hu Zhang F, Shen N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC) JO - Biomed Pharmacother VL - 95 UR - https://doi.org/10.1016/j.biopha.2017.08.057 DO - 10.1016/j.biopha.2017.08.057 ID - He2017 ER - TY - JOUR AU - Tang, Q. AU - Ni, Z. AU - Cheng, Z. AU - Xu, J. AU - Yu, H. AU - Yin, P. PY - 2015 DA - 2015// TI - Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC JO - Cell Physiol Biochem VL - 37 UR - https://doi.org/10.1159/000430226 DO - 10.1159/000430226 ID - Tang2015 ER - TY - JOUR AU - Zhang, Y. AU - Chen, W. J. AU - Gan, T. Q. AU - Zhang, X. L. AU - Xie, Z. C. AU - Ye, Z. H. PY - 2017 DA - 2017// TI - Clinical significance and effect of lncRNA HOXA11-AS in NSCLC: a study based on bioinformatics, in vitro and in vivo verification JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-05856-2 DO - 10.1038/s41598-017-05856-2 ID - Zhang2017 ER - TY - JOUR AU - Yang, Y. -. R. AU - Zang, S. -. Z. AU - Zhong, C. -. L. AU - Li, Y. -. X. AU - Zhao, S. -. S. AU - Feng, X. -. J. PY - 2014 DA - 2014// TI - Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer JO - Int J Clin Exp Pathol VL - 7 ID - Yang2014 ER - TY - JOUR AU - Deng, J. AU - Liang, Y. AU - Liu, C. AU - He, S. AU - Wang, S. PY - 2015 DA - 2015// TI - The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients JO - Biomed Pharmacother VL - 75 UR - https://doi.org/10.1016/j.biopha.2015.07.003 DO - 10.1016/j.biopha.2015.07.003 ID - Deng2015 ER - TY - JOUR AU - Lu, K. H. AU - Li, W. AU - Liu, X. H. AU - Sun, M. AU - Zhang, M. L. AU - Wu, W. Q. PY - 2013 DA - 2013// TI - Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-461 DO - 10.1186/1471-2407-13-461 ID - Lu2013 ER - TY - JOUR AU - Xie, J. -. J. AU - Jiang, Y. -. Y. AU - Jiang, Y. AU - Li, C. -. Q. AU - Lim, M. -. C. AU - An, O. PY - 2018 DA - 2018// TI - Super-enhancer-driven long non-coding RNA LINC01503, regulated by TP63, is over-expressed and oncogenic in squamous cell carcinoma JO - Gastroenterology VL - 154 UR - https://doi.org/10.1053/j.gastro.2018.02.018 DO - 10.1053/j.gastro.2018.02.018 ID - Xie2018 ER - TY - JOUR AU - Yu, T. AU - Liu, L. AU - Li, J. AU - Yan, M. AU - Lin, H. AU - Liu, Y. PY - 2015 DA - 2015// TI - MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.4972 DO - 10.18632/oncotarget.4972 ID - Yu2015 ER - TY - JOUR AU - Jiang, Z. AU - Yin, J. AU - Fu, W. AU - Mo, Y. AU - Pan, Y. AU - Dai, L. PY - 2014 DA - 2014// TI - MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0094639 DO - 10.1371/journal.pone.0094639 ID - Jiang2014 ER - TY - STD TI - Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications. Genet Res Int. 2012;2012. ID - ref16 ER - TY - JOUR AU - Xie, X. AU - Liu, H. AU - Wang, M. AU - Ding, F. AU - Xiao, H. AU - Hu, F. PY - 2015 DA - 2015// TI - miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells JO - Tumor Biol VL - 36 UR - https://doi.org/10.1007/s13277-015-3154-3 DO - 10.1007/s13277-015-3154-3 ID - Xie2015 ER - TY - JOUR AU - Orth, M. F. AU - Cazes, A. AU - Butt, E. AU - Grunewald, T. G. PY - 2015 DA - 2015// TI - An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.3083 DO - 10.18632/oncotarget.3083 ID - Orth2015 ER - TY - JOUR AU - Zheng, J. AU - Wang, F. AU - Lu, S. AU - Wang, X. PY - 2016 DA - 2016// TI - LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer JO - Exp Mol Pathol VL - 100 UR - https://doi.org/10.1016/j.yexmp.2015.11.031 DO - 10.1016/j.yexmp.2015.11.031 ID - Zheng2016 ER - TY - JOUR AU - Hu, Z. AU - Cui, Y. AU - Zhou, Y. AU - Zhou, K. AU - Qiao, X. AU - Li, C. PY - 2016 DA - 2016// TI - MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1 JO - OncoTargets Ther VL - 9 UR - https://doi.org/10.2147/OTT.S116509 DO - 10.2147/OTT.S116509 ID - Hu2016 ER - TY - JOUR AU - Livak, K. J. AU - Schmittgen, T. D. PY - 2001 DA - 2001// TI - Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method JO - Methods. VL - 25 UR - https://doi.org/10.1006/meth.2001.1262 DO - 10.1006/meth.2001.1262 ID - Livak2001 ER - TY - JOUR AU - Byers, R. AU - Ward, T. AU - Womack, C. PY - 2011 DA - 2011// TI - Dive. C. Effect of prolonged formalin fixation on immunohistochemical staining for the proliferation marker Ki67 JO - Histopathology VL - 59 ID - Byers2011 ER - TY - JOUR AU - Lu, S. R. AU - Li, Q. AU - Lu, J. L. AU - Liu, C. AU - Xu, X. AU - Li, J. Z. PY - 2018 DA - 2018// TI - Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492/FOXK1 signaling JO - Exp Ther Med VL - 16 ID - Lu2018 ER - TY - JOUR AU - Qu, Y. AU - Qu, X. AU - Chen, G. AU - Feng, Y. AU - Teng, X. AU - Liu, W. PY - 2019 DA - 2019// TI - LINC01503 promotes cell proliferation, invasion and EMT process in cholangio-carcinoma JO - Eur Rev Med Pharmacol Sci VL - 23 ID - Qu2019 ER - TY - JOUR AU - Xue, X. AU - Fei, X. AU - Hou, W. AU - Zhang, Y. AU - Liu, L. AU - Hu, R. PY - 2018 DA - 2018// TI - miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer JO - Cancer Lett VL - 412 UR - https://doi.org/10.1016/j.canlet.2017.10.024 DO - 10.1016/j.canlet.2017.10.024 ID - Xue2018 ER - TY - JOUR AU - Wang, S. -. H. AU - Ma, F. AU - Tang, Z. H. AU - Wu, X. C. AU - Cai, Q. AU - Zhang, M. D. PY - 2016 DA - 2016// TI - Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0436-6 DO - 10.1186/s13046-016-0436-6 ID - Wang2016 ER - TY - JOUR AU - Cheng, D. AU - Fan, J. AU - Ma, Y. AU - Zhou, Y. AU - Qin, K. AU - Shi, M. PY - 2019 DA - 2019// TI - LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p JO - Cell Bioscience VL - 9 UR - https://doi.org/10.1186/s13578-019-0290-2 DO - 10.1186/s13578-019-0290-2 ID - Cheng2019 ER - TY - JOUR AU - Zhang, X. AU - Liu, Y. AU - Fan, C. AU - Wang, L. AU - Li, A. AU - Zhou, H. PY - 2017 DA - 2017// TI - Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.20527 DO - 10.18632/oncotarget.20527 ID - Zhang2017 ER -